{"id":"W4402460449","doi":"10.1038/s41408-024-01135-2","title":"Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadiana.org; Juravinski Cancer Centre; Ottawa Hospital; University Health Network; CancerCare Manitoba; Princess Margaret Cancer Centre; Vancouver General Hospital; University of British Columbia; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pomalidomide; Dexamethasone; Subgroup analysis; Multiple myeloma; Internal medicine; Oncology; Medicine; Refractory (planetary science); Lenalidomide; Meta-analysis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008681583,0.000266584,0.0007979748,0.0005495988,0.0002469046,0.0001148531,0.0002015372,0.0001585837,0.0002330022],"category_scores_gemma":[0.0006051239,0.0001664156,0.000731747,0.0009758079,0.0001576512,0.000149797,0.00007344074,0.000569396,0.000002032656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000187061,"about_ca_system_score_gemma":0.0006243604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002454908,"about_ca_topic_score_gemma":0.0004455029,"domain_scores_codex":[0.9974869,0.0002284809,0.0006846288,0.0004079039,0.0006784113,0.0005136644],"domain_scores_gemma":[0.9979992,0.0007908572,0.0002639176,0.0003603675,0.0002281693,0.0003574956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1970439,0.004430301,0.4167964,0.001348752,0.07229119,0.001246673,0.002915252,0.00008045576,0.1399008,0.0002172111,0.009287714,0.1544414],"study_design_scores_gemma":[0.4907873,0.007213315,0.3637565,0.001380203,0.03986844,0.001057443,0.0008749503,0.01851294,0.05880657,0.0002269039,0.01675355,0.0007618788],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980953,0.01523797,0.0003011445,0.0009207117,0.0007513479,0.001377152,0.0003380694,0.00003352412,0.00008702069],"genre_scores_gemma":[0.9951115,0.001630145,0.001049253,0.00009733887,0.0007046917,0.000208712,0.00003696584,0.00004896357,0.001112481],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2937434,"threshold_uncertainty_score":0.6786231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03603070339032477,"score_gpt":0.3259702992284997,"score_spread":0.289939595838175,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}